The latest announcement is out from GlaxoSmithKline Pharmaceuticals Limited ( ($IN:GLAXO) ). GlaxoSmithKline Pharmaceuticals Limited has responded ...

Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the October 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain ...

GSK is a leading biopharmaceutical company with a focus on vaccines and products for major diseases. GSK's drug line-up is safe and profitable, with competitors facing larger sales loss exposure due ...

GSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over ...

An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK plc has continued its share buyback programme, repurchasing 232,912 ...

GSK PLC closed 11.41% short of its 52-week high of £20.58, which the company reached on December 19th.

GSK PLC (NYSE:GSK) shares ended its trading session in the green for seventh consecutive day on Wednesday. The stock closed up 0.65% at $42.02. GSK is up 12.7% YTD, compared to the broader S&P 500, ...

Wave Life Sciences Ltd. (NASDAQ:WVE) stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.

Europe's biggest listing in a decade, Haleon, started trading on the London Stock Exchange on Monday. Haleon in the consumer-health business spinoff of GSK . The combined price of Haleon , 331.7 pence ...

Viatris, known for its branded drugs, has several up-and-coming biosimilars. GSK is seeing sales growth even as its COVID-19-related sales decline. Merck spinoff Organon pays a dividend that yields ...